why UnitedHealth Group Incorporated [UNH] is a Good Choice for Investors After New Price Target of $567.21

Related

UnitedHealth Group Incorporated [NYSE: UNH] jumped around 8.0 points on Wednesday, while shares priced at $507.62 at the close of the session, up 1.60%.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

UnitedHealth Group Incorporated stock is now 1.09% up from its year-to-date (YTD) trading value. UNH Stock saw the intraday high of $509.77 and lowest of $493.09 per share. The company’s 52-week high price is 553.29, which means current price is +13.88% above from all time high which was touched on 04/14/22.

Compared to the average trading volume of 3.10M shares, UNH reached a trading volume of 3961564 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about UnitedHealth Group Incorporated [UNH]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $567.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 14, 2021. While these analysts kept the previous recommendation, SVB Leerink raised their target price to Outperform. The new note on the price target was released on September 27, 2021, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $478, while Cowen analysts kept a Outperform rating on UNH stock.

The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 12.84, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.65. The Price to Book ratio for the last quarter was 6.65, with the Price to Cash per share for the same quarter was set at 22.08. Price to Free Cash Flow for UNH in the course of the last twelve months was 27.62.

How has UNH stock performed recently?

UnitedHealth Group Incorporated [UNH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.20. With this latest performance, UNH shares dropped by -0.47% in over the last four-week period, additionally plugging by 12.30% over the last 6 months – not to mention a rise of 23.06% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 44.89, with the RSI for the last a single of trading hit 41.57, and the three-weeks RSI is set at 47.77 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 507.93, while it was recorded at 508.27 for the last single week of trading, and 460.40 for the last 200 days.

UnitedHealth Group Incorporated [UNH]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.33. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +6.01.

Return on Equity for this stock inclined to 25.19, with Return on Assets sitting at 8.30.

Earnings analysis for UnitedHealth Group Incorporated [UNH]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 14.60%.

Insider trade positions for UnitedHealth Group Incorporated [UNH]

There are presently around $412,412 million, or 89.60% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 79,483,862, which is approximately 0.399% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 69,259,425 shares of the stock with an approximate value of $34.6 billion in UNH stocks shares; and FMR LLC, currently with $23.99 billion in UNH stock with ownership of nearly -0.157% of the company’s market capitalization.

Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 1,484 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 25,186,692 shares. Additionally, 1,176 investors decreased positions by around 23,438,693 shares, while 327 investors held positions by with 776,826,952 shares. The mentioned changes placed institutional holdings at 825,452,337 shares, according to the latest SEC report filing. UNH stock had 284 new institutional investments in for a total of 2,783,068 shares, while 96 institutional investors sold positions of 2,084,791 shares during the same period.